March 2013 Scientist to Watch Emily Scott explains her work on a lung enzyme that interacts with nicotine and may serve as a drug target.
By Dan Cossins | March 1, 2013
Read the full story.
Sign In with your LabX Media Group Passport to leave a comment
Not a member? Register Now!
March 14, 2013
Any drug they will develop to block the enzyme will have side effects. So, a better approach is to quit smoking. Mochael Lerman, M.D., Ph.D.
By Kerry Grens
Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.
By Bob Grant
The predatory toxins employed by animals separated by millions of years of evolution are virtually identical, a study shows.
By Ruth Williams
A new high-throughput, transcriptome-wide assay determines RNA structures in vivo.
And too few insights gleaned from them
Antibiotics given to infant mice may have long-term effects on the animals’ metabolism and gut microbiota.
Male and female mice utilize different immune cells to process pain, a study shows.
Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.
View the Jully 2015 contents.
© 1986-2015 The Scientist